Date: Wednesday 25th September 2024
Time: 12:30-2:00pm
Venue: Early Cancer Institute, Adrian Way, Cambridge CB2 0XZ
Register at: https://eci-seminar-manuel-collado.eventbrite.co.uk
The seminar series from the Early Cancer Institute aims to connect researchers in the early cancer detection and diagnosis space to share knowledge and spark collaboration. Join fellow researchers for lunch and an opportunity to network.
On Wednesday 25th September we welcome Manuel Collado from the Health Research Institute of Santiago de Compostela, IDIS, to give a talk: 'Harnessing cellular reprogramming to improve human health.'
This event will take place in the Early Cancer Institute, Adrian Way, Cambridge Biomedical Campus, Cambridge, CB2 0XZ
Lunch is provided from 12:30pm, the talk will begin at 1.00pm followed by a Q&A. Please ensure you arrive promptly.
Note that this event is on a Wednesday and not our usual Tuesday lunchtime.
Speaker Biography:
Manuel Collado has led the Cell Senescence, Cancer and Aging Laboratory at The Center for Research in Molecular Medicine and Chronic Diseases (CiMUS) in Santiago de Compostela, Spain since 2012.
Manuel obtained his PhD at UAM in Madrid in 1997 for work done at CNB-CSIC and held postdoctoral positions first at the Ludwig Institute for Cancer Research in London, UK, and later at NYU Medical School and at Memorial Sloan Kettering Cancer Center in New York, USA. He returned to Madrid, Spain in 2001 to join Manuel Serrano´s group at CNB.
During his career, he has published close to 80 papers, several of them in high impact journal such as Nature (3 articles), Cell, Cancer Cell, Cell Stem Cell, PNAS, EMBO J, Genes & Development, Nature Communications, Aging Cell, Cancer Research, etc. He is also the author of some the most cited reviews in his field published in Nature Reviews Cancer (2 reviews) and Cell (3 reviews).
His scientific work has been mainly focused on cancer and in particular tumour suppression mechanisms, working primarily on cell senescence. On this subject he has published more than 30 articles, among them the first in-vivo description of oncogene-induced senescence in Nature (more than 1000 citations).
